Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,358.18 -2,240.72 (-3.36%) CMC Crypto 200
1,387.62 -36.48 (-2.56%)
Boston Scientific Corporation (BSX)
After hours:
- Benzinga
Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars
Boston Scientific Corporation (NYSE:BSX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter earnings and issued guidance. The company generated first-quarter revenues of $3.86 billion, beating the consensus estimate of $3.69 billion. Sales soared 13.8% year-over-year on a reported basis, 15% on an operational basis, and 13.1% on an organic basis, beating the management guidance of approximately 7.5%-9.5% on a reported basis and approximately 7%-9
- Zacks
Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
- Barrons.com
Boston Scientific Stock Rises on More Than Just an Earnings Beat
FEATURE Shares of Boston Scientific were trading higher after the medical-device company topped quarterly estimates and issued strong guidance. For its first quarter, Boston Scientific reported adjusted earnings per share of 56 cents, higher than the 51 cents Wall Street had expected, according to FactSet.
